SINTX Technologies Advances SiN/PEEK 3D Printing Platform Toward Personalized Orthopedic Implant CommercializationGlobeNewsWire • Wednesday
Sintx Technologies, Inc. (SINT) Q3 2026 Earnings Call Prepared Remarks TranscriptSeeking Alpha • 11/06/26
SINTX Reports Record Third Quarter 2026 Revenue Growth and Advances Medical Device CommercializationGlobeNewsWire • 11/05/26
SINTX Technologies Announces Third Quarter 2026 Earnings Release Date and WebcastGlobeNewsWire • 10/22/26
SINTX Announces Preliminary $2.2 Million in Q3 Revenue, Exceeding High-End GuidanceGlobeNewsWire • 10/01/26
SINTX Technologies Announces Silicon Nitride Masterclass with Leading Orthopedics ExpertsGlobeNewsWire • 09/14/26
SINTX Technologies to Present at the H.C. Wainwright 28th Annual Global Investment ConferenceGlobeNewsWire • 09/08/26
SINTX TECHNOLOGIES (SINT) Moves to Buy: Rationale Behind the UpgradeZacks Investment Research • 08/19/26
SINTX Technologies Regains Compliance with Nasdaq Stockholders' Equity RequirementGlobeNewsWire • 08/13/26
Sintx Technologies, Inc. (SINT) Q2 2026 Earnings Call Prepared Remarks TranscriptSeeking Alpha • 08/11/26
SINTX Technologies Provides Mid-Year 2026 Business Update Highlighting Commercial Execution, Biomaterial Platform Expansion and Strategic Growth InitiativesGlobeNewsWire • 08/11/26
SINTX Technologies Announces Second Quarter 2026 Earnings Release Date and WebcastGlobeNewsWire • 07/28/26
SINTX Technologies Engages Veteran MedTech Executive Chris Lyons and Southern Metrics to Establish Strategic Opportunity Management ProgramGlobeNewsWire • 07/23/26
SINTX Technologies Announces Receipt of More Than $3.2 Million in Contract Manufacturing Purchase OrdersGlobeNewsWire • 06/22/26
SINTX Technologies Announces Raise of Approximately $5.0 Million of Capital, Including a $4.5 Million Private Placement Priced At-the-Market Under Nasdaq RulesGlobeNewsWire • 06/03/26
SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial ExecutionGlobeNewsWire • 03/23/26
SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle ImplantGlobeNewsWire • 03/19/26
SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial PlatformsGlobeNewsWire • 02/18/26
SINTX Technologies to Participate in Noble Capital Markets' Emerging Growth Virtual Equity Conference on February 4–5GlobeNewsWire • 01/29/26
SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific ImplantsGlobeNewsWire • 12/01/25
SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge SystemGlobeNewsWire • 11/03/25
SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant SystemGlobeNewsWire • 10/20/25
What Makes SINTX TECHNOLOGIES, INC. (SINT) a Strong Momentum Stock: Buy Now?Zacks Investment Research • 10/16/25